Myopathy secondary to empagliflozin therapy in type 2 diabetes.
Enhancing diabetic muscle repair through W-GA nanodots: a nanomedicinal approach to ameliorate myopathy in type 2 diabetes.
[Mitochondrial myopathy, deafness and type 2 diabetes mellitus with tRNALeu(UUR) point mutation in mitochondrial DNA].
Pathogenesis and comprehensive treatment strategies of sarcopenia in elderly patients with type 2 diabetes mellitus.
Hou Y, Xiang J, Wang B, Duan S, Song R, Zhou W, Tan S, He B.
Front Endocrinol (Lausanne). 2024 Jan 8;14:1263650. doi: 10.3389/fendo.2023.1263650. eCollection 2023.
Human skeletal muscle CD90+ fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetic patients.
Farup J, Just J, de Paoli F, Lin L, Jensen JB, Billeskov T, Roman IS, Cömert C, Møller AB, Madaro L, Groppa E, Fred RG, Kampmann U, Gormsen LC, Pedersen SB, Bross P, Stevnsner T, Eldrup N, Pers TH, Rossi FMV, Puri PL, Jessen N.
Cell Metab. 2021 Nov 2;33(11):2201-2214.e11. doi: 10.1016/j.cmet.2021.10.001. Epub 2021 Oct 21.
Skeletal muscle mitochondrial remodeling in exercise and diseases.
Gan Z, Fu T, Kelly DP, Vega RB.
Cell Res. 2018 Oct;28(10):969-980. doi: 10.1038/s41422-018-0078-7. Epub 2018 Aug 14.
The impact of type 2 diabetes on the development of tendinopathy.
Cannata F, Vadalà G, Ambrosio L, Napoli N, Papalia R, Denaro V, Pozzilli P.
Diabetes Metab Res Rev. 2021 Sep;37(6):e3417. doi: 10.1002/dmrr.3417. Epub 2020 Nov 6.
Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction.
Lee SJ.
J Clin Invest. 2021 May 3;131(9):e148372. doi: 10.1172/JCI148372.
Rehabilitation of Individuals With Diabetes Mellitus: Focus on Diabetic Myopathy.
Bassi-Dibai D, Santos-de-Araújo AD, Dibai-Filho AV, de Azevedo LFS, Goulart CDL, Luz GCP, Burke PR, Garcia-Araújo AS, Borghi-Silva A.
Front Endocrinol (Lausanne). 2022 Apr 14;13:869921. doi: 10.3389/fendo.2022.869921. eCollection 2022.
Do most patients with obesity or type 2 diabetes, and atrial fibrillation, also have undiagnosed heart failure? A critical conceptual framework for understanding mechanisms and improving diagnosis and treatment.
Packer M.
Eur J Heart Fail. 2020 Feb;22(2):214-227. doi: 10.1002/ejhf.1646. Epub 2019 Dec 17.
Skeletal Muscle and Metabolic Health: How Do We Increase Muscle Mass and Function in People with Type 2 Diabetes?
Al-Ozairi E, Alsaeed D, Alroudhan D, Voase N, Hasan A, Gill JMR, Sattar N, Welsh P, Gray CM, Boonpor J, Celis-Morales C, Gray SR.
J Clin Endocrinol Metab. 2021 Jan 23;106(2):309-317. doi: 10.1210/clinem/dgaa835.
DNA methylation in the pathogenesis of type 2 diabetes.
Kaimala S, Ansari SA, Emerald BS.
Vitam Horm. 2023;122:147-169. doi: 10.1016/bs.vh.2022.11.002. Epub 2022 Dec 16.
High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study.
Mori H, Kuroda A, Yoshida S, Yasuda T, Umayahara Y, Shimizu S, Ryomoto K, Yoshiuchi K, Yamamoto T, Matsuoka TA, Shimomura I, Matsuhisa M.
J Diabetes Investig. 2021 Jun;12(6):1050-1059. doi: 10.1111/jdi.13436. Epub 2020 Nov 20.
